Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 251

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Association of Serial Biochemical Markers With Acute Ischemic Stroke: The National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study

Jauch, Edward C., Lindsell, Christopher, Broderick, Joseph, Fagan, Susan C., Tilley, Barbara C., Levine, Steven R.·2006·Stroke

Abstract

Background and Purpose— Biochemical markers of acute neuronal injury may aid in the diagnosis and management of acute ischemic stroke. Serum samples from the National Institute for Neurological Disorders and Stroke (NINDS) recombinant tissue plasminogen activator Stroke Study were analyzed for the presence of 4 biochemical markers of neuronal, glial, and endothelial cell injury. These biochemical markers, myelin basic protein (MBP), neuron-specific enolase (NSE), S100β, and soluble thrombomodulin, were studied for an association with initial stroke severity, infarct volume, and functional outcome. Methods— In the original NINDS study, serum samples were drawn from all patients on presentation to the Emergency Department and at ≈2 and 24 hours after initiation of study therapy. In this analysis, stored serum samples were available for 359 patients; 107 patients had samples for all 3 time points. Serum marker concentrations were measured by ELISA techniques. We examined the relation between serum concentrations of each marker and the degree of baseline neurological deficit, functional outcome, and infarct size on computed tomography at 24 hours and the effect of fibrinolytic therapy. Results— Higher 24-hour peak concentrations of MBP, NSE, and S100β were associated with higher National Institutes of Health Stroke Scale baseline scores ( r =0.186, P <0.0001; r =0.117, P =0.032; and r =0.263, P <0.0001, respectively). Higher peak concentrations of MBP and S100β ( r =0.209, P <0.0001; r =0.239, P <0.0001) were associated with larger computed tomography lesion volumes. Patients with favorable outcomes had smaller changes in MBP and S100β ( P <0.05) concentrations in the first 24 hours. Soluble thrombomodulin was not associated with any severity or outcome measure. Conclusions— This study corroborates previous work demonstrating correlations of MBP, NSE, and S100β with clinical and radiographic features in acute stroke. Despite significantly better outcomes in the tissue plasminogen activator–treated group, we found no difference in the early release of the 4 biomarkers between treatment groups. Further study will define the role of biomarkers in acute stroke management and prognostication.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.str.0000242290.01174.9e

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 251

Metadata

Authors
Jauch, E. C., Lindsell, C., Broderick, J., Fagan, S. C., Tilley, B. C., & Levine, S. R.
Venue
Stroke
Published
2006-10
Volume
37
Issue
10
Pages
2508-2513
ISSN
  • 0039-2499 (ISSN-L)
  • 1524-4628
OpenAlex
W2122906454
Cited by
251
References
1
FWCI
7.75
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association of Serial Biochemical Markers With Acute Ischemic Stroke: The National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. https://app.cochat.ai/papers/10.1161/01.str.0000242290.01174.9e
The paper
Jauch, E. C., Lindsell, C., Broderick, J., Fagan, S. C., Tilley, B. C., & Levine, S. R. (2006). Association of Serial Biochemical Markers With Acute Ischemic Stroke: The National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. Stroke. https://doi.org/10.1161/01.str.0000242290.01174.9e

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.